U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07869121) titled 'Achilles Non-SNIS REGENETEN' on Oct. 02.
Brief Summary: The proposed study addresses this gap by prospectively evaluating patient-reported outcomes, imaging endpoints, and safety through 12 months after BCI-augmented repair in IAT and MSR patients. The purpose is to evaluate clinical outcomes (effectiveness) following the use of REGENETEN to augment Achilles tendon surgical procedures.
Study Start Date: Aug. 03
Study Type: OBSERVATIONAL
Condition:
Complete Mid-portion Achilles Rupture
Intervention:
DEVICE: REGENETEN
The REGENETEN Bioinductive Implant is a scaffold made from highly purified type I collagen fibers. Following fi...